News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100 Results
Type
Article (8)
Press Release (92)
Section
Business (31)
Deals (7)
Drug Development (21)
FDA (3)
News (64)
Policy (5)
Tag
Alliances (16)
Approvals (4)
Cancer (1)
Clinical research (22)
Collaboration (1)
COVID-19 (2)
Data (2)
Diabetes (1)
Earnings (9)
Events (9)
FDA (5)
GLP-1 (1)
Government (1)
Healthcare (1)
Infectious disease (2)
Legal (1)
Mergers & acquisitions (7)
Metabolic disorders (1)
Patient recruitment (1)
People (7)
Phase 1 (5)
Phase 2 (10)
Phase 3 (7)
Pipeline (2)
Regulatory (6)
Date
Last 365 days (7)
2025 (7)
2024 (7)
2023 (7)
2022 (10)
2021 (2)
2020 (7)
2019 (5)
2018 (5)
2017 (5)
2016 (2)
2015 (2)
2014 (2)
2013 (6)
2012 (4)
2011 (4)
2010 (2)
Location
Asia (4)
California (5)
Canada (2)
Europe (38)
Florida (2)
Northern California (2)
Ohio (2)
South America (1)
Southern California (3)
United States (9)
100 Results for "dompe".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dompé Doses First Patients in Europe and US in Phase 3 Study of Isocyclosporin for Atopic Keratoconjunctivitis
December 17, 2025
·
4 min read
Press Releases
Dompé’s Program in NAION Selected for Landmark FDA Commissioner’s National Priority Voucher Program
October 16, 2025
·
6 min read
Press Releases
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
October 29, 2025
·
3 min read
Press Releases
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
October 28, 2025
·
8 min read
Business
Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech
Dompé today announced the appointment of Shannon K. Sullivan as Chief Commercial Officer (CCO), effective immediately.
October 10, 2023
·
3 min read
Business
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Jaguar Health, Inc. today announced that Massimo Radaelli, PhD, has been appointed President of Jaguar International.
April 2, 2024
·
7 min read
Press Releases
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
December 20, 2024
·
9 min read
Policy
Neurotrophic Keratitis: EMA Validates The Marketing Authorisation Application For Cenegermin Eye Drops (Oxervate) Submitted By Dompe
December 12, 2016
·
5 min read
Dompe Receives Positive CHMP Opinion In Europe For Oxervate (Cenegermin Eye Drops) For The Treatment Of Adult Patients With Moderate Or Severe Neurotrophic Keratitis
May 23, 2017
·
4 min read
News
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
October 10, 2024
·
2 min read
1 of 10
Next
